Editorial: When and What to Ask-Capturing the Symptoms Experienced by Patients With PSC

Affiliations

¹ Division of Gastroenterology and Hepatology, University of California Davis School of Medicine, Sacramento, California, USA.
² Division of Gastroenterology and Hepatology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Editorial

Christopher L Bowlus et al. Aliment Pharmacol Ther. 2025 Jun.

. 2025 Jun;61(11):1826-1827.

doi: 10.1111/apt.70127. Epub 2025 Apr 15.

¹ Division of Gastroenterology and Hepatology, University of California Davis School of Medicine, Sacramento, California, USA.
² Division of Gastroenterology and Hepatology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

No abstract available

References

1. A. Kuo, R. Gomel, R. Safer, K. D. Lindor, G. T. Everson, and C. L. Bowlus, “Characteristics and Outcomes Reported by Patients With Primary Sclerosing Cholangitis Through an Online Registry,” Clinical Gastroenterology and Hepatology 17, no. 7 (2019): 1372–1378.
1. N. Tan, C. Zampogna, K. Lynch, et al., “Patient Reported Outcomes in Primary Sclerosing Cholangitis: An Australian Perspective,” Alimentary Pharmacology & Therapeutics 61, no. 10 (2025): 1612–1621.
1. Z. M. Younossi, A. Afendy, M. Stepanova, et al., “Development and Validation of a Primary Sclerosing Cholangitis‐Specific Patient‐Reported Outcomes Instrument: The PSC PRO,” Hepatology 68, no. 1 (2018): 155–165.
1. K. N. van Munster, M. G. W. Dijkgraaf, R. P. J. Oude Elferink, U. Beuers, and C. Y. Ponsioen, “Symptom Patterns in the Daily Life of PSC Patients,” Liver International 42, no. 7 (2022): 1562–1570.
1. R. Dean, M. Yazdanfar, J. Zepeda, I. J. Patel, C. Levy, and C. Lammert, “Investigating the Cholestatic Pruritus of Primary Sclerosing Cholangitis (ItCh‐PSC): A Cross‐Sectional Study of Patients Participating in the Consortium for Autoimmune Liver Disease (CALiD),” Hepatology (San Diego, CA) 80 (2024): S1‐S2011.